Two Sigma Advisers »

Design Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6M 585k 2.65
2023-09-30 $266k 113k 2.36
2023-06-30 $498k 79k 6.30
2023-03-31 $270k 47k 5.77